Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Genes Immun ; 9(8): 706-20, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18784731

ABSTRACT

B-cell development occurs in a stepwise fashion that can be followed by the expression of B cell-specific surface markers. In this study, we wished to identify proteins that could contribute to the changes in expression of such markers. By using RNA from freshly isolated B220+ cells, we hoped to reduce the effect of artifacts that occur during the isolation and amplification steps necessary to use flow cytometry analysis-sorted subsets in microarray experiments. Analyses comparing expression patterns from B220+ 2-week bone marrow (pro-B, pre-B, immature B cells), 2-week spleen (predominantly transitional cells) and 8-week spleen (mainly mature B cells) yielded hundreds of genes. We also examined the B cell-activating factor (BAFF)-dependent effects on immature splenic B cells by comparing expression patterns in the spleen between 2-week A/J vs 2-week A/WySnJ mice, which lack functional BAFF receptor signaling. Genes that showed the expression differences between spleen and bone marrow samples were then analyzed through quantitative PCR on B-cell subsets isolated using two different sorting protocols. A comparison of the results from our study with the results from other analyses showed not only some overlap of preferentially expressed genes but also an expansion of other genes potentially involved in B-cell development.


Subject(s)
B-Cell Activating Factor/genetics , B-Cell Activation Factor Receptor/genetics , B-Lymphocyte Subsets/metabolism , Bone Marrow Cells/metabolism , Cell Differentiation/genetics , Spleen/metabolism , Animals , B-Cell Activating Factor/immunology , B-Cell Activating Factor/metabolism , B-Cell Activation Factor Receptor/immunology , B-Cell Activation Factor Receptor/metabolism , B-Lymphocyte Subsets/immunology , Bone Marrow Cells/immunology , Cell Differentiation/immunology , Gene Expression Profiling , Mice , Mice, Inbred Strains , Oligonucleotide Array Sequence Analysis , Signal Transduction , Spleen/immunology , Transcription, Genetic
2.
J Bone Miner Res ; 18(2): 278-88, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12568405

ABSTRACT

The microphthalmic (mi) mouse possesses a dominant negative mutation in the microphthalmia-associated transcript factor (MITF) transcription factor. These animals are characterized by reduced numbers of peripheral mast and natural killer (NK) cells, are osteopetrotic because of osteoclast reduction and malfunction, lack functional melanocytes, and are deficient for maturing B-cells within the bone marrow. Granulocyte precursor cells, however, are functionally maintained within the mi bone marrow. A central question has been whether the B-cell deficiency of the mi mouse marrow is caused by the absence of an MITF-controlled gene product or because of the compromised, osteopetrotic environment. In this report, we examined mi marrow by performing transcriptional mapping analyses of candidate genes whose products are instrumental for functional osteoclast and B-cell development. Surprisingly, the expression of a subset of such genes including RANKL, stromal-derived factor (SDF-1), B-cell lymphotactin chemokine (BLC), and RANK was dramatically enhanced in the mi marrow. Normal and mutant marrow were also analyzed by subtractive transcript cloning, which identified a number of known and unknown genes with altered transcriptional activity. One such unknown mouse gene possesses a human counterpart that is interferon-beta (IFN-beta) inducible, suggesting the osteopetrotic marrow is enriched for IFN-beta, a cytokine that is known to eliminate B-cell precursors. A model is proposed suggesting excess RANKL sets off a cascade of cytokine production including IFN-beta that leads to the preferential elimination of B-cell precursors in the marrow of osteopetrotic marrow.


Subject(s)
B-Lymphocytes/metabolism , Carrier Proteins/physiology , Interferon-beta/metabolism , Membrane Glycoproteins/physiology , Microphthalmos/genetics , Amino Acid Sequence , Animals , Bone Marrow Cells , Femur/pathology , Gene Expression Profiling , Genotype , Macrophages/metabolism , Mice , Microphthalmos/metabolism , Models, Biological , Molecular Sequence Data , Osteoclasts/metabolism , RANK Ligand , RNA/metabolism , Receptor Activator of Nuclear Factor-kappa B , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Time Factors , Transcription, Genetic
3.
J Immunol ; 163(12): 6671-8, 1999 Dec 15.
Article in English | MEDLINE | ID: mdl-10586063

ABSTRACT

The microphthalmic mouse (mi) possesses a 3-bp deletion of the Mi gene that alters the DNA binding site of the transcription factor gene product. This animal has diminished numbers of NK and mast cells (MC) and is osteopetrotic due to a lack of the normal complement of functional osteoclasts. The reduction of MC has been proposed to be due to the lack of adequate c-Kit expression that is required for MC differentiation. However, data from other labs has questioned this interpretation. In this report, we present data suggesting bone marrow-derived deficiencies of the mi mouse are not due to a lack of c-Kit expression and function, but instead due to an inhospitable environment within the bone marrow itself. Specifically, we have found that such animals also lack virtually all B cell precursors within the marrow and rely upon other lymphatic sites, such as the spleen, for B cell development and maturation. Although the animal has depressed numbers of NK cells, B cells, and MC, it still possesses a normal thymus and peripheral T cells. Therefore, the block in cellular differentiation must be within the marrow environment, which is essential for maturing B cells, NK cells, and MC but not T cells.


Subject(s)
B-Lymphocytes/immunology , Killer Cells, Natural/pathology , Lymphopenia/immunology , Lymphopenia/pathology , Mast Cells/pathology , Microphthalmos/immunology , Microphthalmos/pathology , Animals , Bone Marrow Cells/metabolism , Bone Marrow Cells/pathology , Cell Division/genetics , Cell Division/immunology , Colony-Forming Units Assay , Interleukin-3/physiology , Interleukin-7/physiology , Killer Cells, Natural/immunology , Killer Cells, Natural/metabolism , Leukocyte Count , Lymphopenia/genetics , Mast Cells/immunology , Mast Cells/metabolism , Mice , Mice, Mutant Strains , Microphthalmos/genetics , Peyer's Patches/metabolism , Peyer's Patches/pathology , Proto-Oncogene Proteins c-kit/biosynthesis , Proto-Oncogene Proteins c-kit/physiology , Spleen/metabolism , Spleen/pathology , Stem Cell Factor/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...